Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation: Results From the CERTAIN Study.

Stoler MH, Wright TC Jr, Ferenczy A, Ranger-Moore J, Fang Q, Kapadia M, Ridder R.

Am J Surg Pathol. 2018 Aug;42(8):1001-1009. doi: 10.1097/PAS.0000000000001072.

PMID:
29697437
2.

Whole tumor section quantitative image analysis maximizes between-pathologists' reproducibility for clinical immunohistochemistry-based biomarkers.

Barnes M, Srinivas C, Bai I, Frederick J, Liu W, Sarkar A, Wang X, Nie Y, Portier B, Kapadia M, Sertel O, Little E, Sabata B, Ranger-Moore J.

Lab Invest. 2017 Dec;97(12):1508-1515. doi: 10.1038/labinvest.2017.82. Epub 2017 Aug 14.

3.

Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.

Wright TC Jr, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, Ridder R.

Gynecol Oncol. 2017 Jan;144(1):51-56. doi: 10.1016/j.ygyno.2016.10.031. Epub 2016 Oct 27.

PMID:
28094038
4.

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.

Hirsch FR, McElhinny A, Stanforth D, Ranger-Moore J, Jansson M, Kulangara K, Richardson W, Towne P, Hanks D, Vennapusa B, Mistry A, Kalamegham R, Averbuch S, Novotny J, Rubin E, Emancipator K, McCaffery I, Williams JA, Walker J, Longshore J, Tsao MS, Kerr KM.

J Thorac Oncol. 2017 Feb;12(2):208-222. doi: 10.1016/j.jtho.2016.11.2228. Epub 2016 Nov 29.

5.

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients.

Kurozumi S, Padilla M, Kurosumi M, Matsumoto H, Inoue K, Horiguchi J, Takeyoshi I, Oyama T, Ranger-Moore J, Allred DC, Dennis E, Nitta H.

Breast Cancer Res Treat. 2016 Jul;158(1):99-111. doi: 10.1007/s10549-016-3856-2. Epub 2016 Jun 18.

6.

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests.

Vyberg M, Nielsen S, Røge R, Sheppard B, Ranger-Moore J, Walk E, Gartemann J, Rohr UP, Teichgräber V.

BMC Health Serv Res. 2015 Aug 29;15:352. doi: 10.1186/s12913-015-1018-6.

7.

New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assay.

Nitta H, Tsuta K, Yoshida A, Ho SN, Kelly BD, Murata LB, Kosmeder J, White K, Ehser S, Towne P, Schemp C, McElhinny A, Ranger-Moore J, Bieniarz C, Singh S, Tsuda H, Grogan TM.

J Thorac Oncol. 2013 Aug;8(8):1019-31. doi: 10.1097/JTO.0b013e31829ebb4d.

8.

Biphasic change of tau (τ) in mice as arterial load acutely increased with phenylephrine injection.

Yang B, Larson DF, Ranger-Moore J.

PLoS One. 2013 Apr 8;8(4):e60580. doi: 10.1371/journal.pone.0060580. Print 2013.

9.

Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.

Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, Thompson PA, Slate E, Hsu CH, Dalkin BL, Sindhwani P, Holmes MA, Tuckey JA, Graham DL, Parnes HL, Clark LC, Stratton SP.

Prostate. 2013 Feb 15;73(3):328-35. doi: 10.1002/pros.22573. Epub 2012 Aug 10.

10.

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.

Nitta H, Kelly BD, Padilla M, Wick N, Brunhoeber P, Bai I, Singh S, Ranger-Moore J, Bieniarz C, Tsuda H, Grogan TM.

Diagn Pathol. 2012 May 30;7:60. doi: 10.1186/1746-1596-7-60.

11.

Thymidylate synthase protein expression by IHC and gene copy number by SISH correlate and show great variability in non-small cell lung cancer.

Wynes MW, Konopa K, Singh S, Reyna-Asuncion B, Ranger-Moore J, Sternau A, Christoph DC, Dziadziuszko R, Jassem J, Hirsch FR.

J Thorac Oncol. 2012 Jun;7(6):982-92. doi: 10.1097/JTO.0b013e31824fe95a.

12.

Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer.

Dziadziuszko R, Wynes MW, Singh S, Asuncion BR, Ranger-Moore J, Konopa K, Rzyman W, Szostakiewicz B, Jassem J, Hirsch FR.

J Thorac Oncol. 2012 Feb;7(2):340-7. doi: 10.1097/JTO.0b013e318240ca0d.

13.

EGFR protein expression in non-small cell lung cancer predicts response to an EGFR tyrosine kinase inhibitor--a novel antibody for immunohistochemistry or AQUA technology.

Mascaux C, Wynes MW, Kato Y, Tran C, Asuncion BR, Zhao JM, Gustavson M, Ranger-Moore J, Gaire F, Matsubayashi J, Nagao T, Yoshida K, Ohira T, Ikeda N, Hirsch FR.

Clin Cancer Res. 2011 Dec 15;17(24):7796-807. doi: 10.1158/1078-0432.CCR-11-0209. Epub 2011 Oct 12.

14.

Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer.

Algotar AM, Stratton SP, Ranger-Moore J, Stratton MS, Hsu CH, Ahmann FR, Nagle RB, Thompson PA.

Am J Mens Health. 2011 May;5(3):272-8. doi: 10.1177/1557988310390030.

15.

Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity.

Algotar AM, Thompson PA, Ranger-Moore J, Stratton MS, Hsu CH, Ahmann FR, Nagle RB, Stratton SP.

Intern Med J. 2012 Apr;42(4):374-80. doi: 10.1111/j.1445-5994.2011.02473.x.

16.

Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer.

Badzio A, Wynes MW, Dziadziuszko R, Merrick DT, Pardo M, Rzyman W, Kowalczyk A, Singh S, Ranger-Moore J, Manriquez G, Gaire F, Jassem J, Hirsch FR.

J Thorac Oncol. 2010 Dec;5(12):1905-11. doi: 10.1097/JTO.0b013e3181f38f57.

17.

Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.

Stratton MS, Algotar AM, Ranger-Moore J, Stratton SP, Slate EH, Hsu CH, Thompson PA, Clark LC, Ahmann FR.

Cancer Prev Res (Phila). 2010 Aug;3(8):1035-43. doi: 10.1158/1940-6207.CAPR-09-0143. Epub 2010 Jul 20.

18.

Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility.

Papouchado BG, Myles J, Lloyd RV, Stoler M, Oliveira AM, Downs-Kelly E, Morey A, Bilous M, Nagle R, Prescott N, Wang L, Dragovich L, McElhinny A, Garcia CF, Ranger-Moore J, Free H, Powell W, Loftus M, Pettay J, Gaire F, Roberts C, Dietel M, Roche P, Grogan T, Tubbs R.

Am J Surg Pathol. 2010 Jun;34(6):767-76. doi: 10.1097/PAS.0b013e3181d96231.

PMID:
20421783
19.

Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity.

Algotar AM, Thompson PA, Ranger-Moore J, Stratton MS, Hsu CH, Ahmann FR, Nagle RB, Stratton SP.

Prostate. 2010 Jun 1;70(8):883-8. doi: 10.1002/pros.21122.

20.

Leaning during chest compressions impairs cardiac output and left ventricular myocardial blood flow in piglet cardiac arrest.

Zuercher M, Hilwig RW, Ranger-Moore J, Nysaether J, Nadkarni VM, Berg MD, Kern KB, Sutton R, Berg RA.

Crit Care Med. 2010 Apr;38(4):1141-6. doi: 10.1097/CCM.0b013e3181ce1fe2.

21.

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease.

Fisher CD, Lickteig AJ, Augustine LM, Ranger-Moore J, Jackson JP, Ferguson SS, Cherrington NJ.

Drug Metab Dispos. 2009 Oct;37(10):2087-94. doi: 10.1124/dmd.109.027466. Epub 2009 Aug 3.

22.

Automatic segmentation of cell nuclei in bladder and skin tissue for karyometric analysis.

Korde VR, Bartels H, Barton J, Ranger-Moore J.

Anal Quant Cytol Histol. 2009 Apr;31(2):83-9.

23.

Wilderness rescue and border enforcement along the Arizona Mexico border--the Border Patrol Search, Trauma and Rescue Unit.

Keim SM, Reiser F, Shetty S, Ranger-Moore J.

Wilderness Environ Med. 2009 Spring;20(1):39-42. doi: 10.1580/08-WEME-OR-245.1.

PMID:
19364185
24.

Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.

Foote JA, Ranger-Moore JR, Einspahr JG, Saboda K, Kenyon J, Warneke J, Miller RC, Goldman R, Xu MJ, Roe DJ, Alberts DS.

Cancer Prev Res (Phila). 2009 Apr;2(4):394-400. doi: 10.1158/1940-6207.CAPR-08-0210. Epub 2009 Mar 31.

25.

Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.

Frank DH, Kimler BF, Fabian CJ, Ranger-Moore J, Yozwiak M, Bartels HG, Alberts DS, Bartels PH.

Breast Cancer Res Treat. 2009 Jun;115(3):661-8. doi: 10.1007/s10549-008-0274-0. Epub 2009 Jan 6.

PMID:
19125322
26.

Phase 1 study of topical perillyl alcohol cream for chemoprevention of skin cancer.

Stratton SP, Saboda KL, Myrdal PB, Gupta A, McKenzie NE, Brooks C, Salasche SJ, Warneke JA, Ranger-Moore J, Bozzo PD, Blanchard J, Einspahr JG, Dorr RT, Levine N, Alberts DS.

Nutr Cancer. 2008;60(3):325-30. doi: 10.1080/01635580701840391.

PMID:
18444166
27.

Cross-validation of murine UV signal transduction pathways in human skin.

Einspahr JG, Bowden GT, Alberts DS, McKenzie N, Saboda K, Warneke J, Salasche S, Ranger-Moore J, Curiel-Lewandrowski C, Nagle RB, Nickoloff BJ, Brooks C, Dong Z, Stratton SP.

Photochem Photobiol. 2008 Mar-Apr;84(2):463-76. doi: 10.1111/j.1751-1097.2007.00287.x. Epub 2008 Jan 29.

PMID:
18248498
28.

Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.

Benbrook DM, Lightfoot S, Ranger-Moore J, Liu T, Chengedza S, Berry WL, Dozmorov I.

Gene Regul Syst Bio. 2008;2:21-42.

29.

Psychosocial and behavioral profile and predictors of self-reported energy underreporting in obese middle-aged women.

Abbot JM, Thomson CA, Ranger-Moore J, Teixeira PJ, Lohman TG, Taren DL, Cussler E, Going SB, Houtkooper LB.

J Am Diet Assoc. 2008 Jan;108(1):114-9.

PMID:
18155996
30.

Karyometry of the colonic mucosa.

Alberts DS, Einspahr JG, Krouse RS, Prasad A, Ranger-Moore J, Hamilton P, Ismail A, Lance P, Goldschmid S, Hess LM, Yozwiak M, Bartels HG, Bartels PH.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2704-16.

31.

Using optical coherence tomography to evaluate skin sun damage and precancer.

Korde VR, Bonnema GT, Xu W, Krishnamurthy C, Ranger-Moore J, Saboda K, Slayton LD, Salasche SJ, Warneke JA, Alberts DS, Barton JK.

Lasers Surg Med. 2007 Oct;39(9):687-95.

32.

Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.

Einspahr JG, Thomas TL, Saboda K, Nickolof BJ, Warneke J, Curiel-Lewandrowski C, Ranger-Moore J, Duckett L, Bangert J, Fruehauf JP, Alberts DS.

Cancer. 2007 Dec 1;110(11):2519-27.

33.

Modulation of human glutathione s-transferases by polyphenon e intervention.

Chow HH, Hakim IA, Vining DR, Crowell JA, Tome ME, Ranger-Moore J, Cordova CA, Mikhael DM, Briehl MM, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1662-6.

34.

Karyometry of breast epithelial cells acquired by random periareolar fine needle aspiration in women at high risk for breast cancer.

Bartels PH, Fabian CJ, Kimler BF, Ranger-Moore JR, Frank DH, Yozwiak ML, Alberts DS.

Anal Quant Cytol Histol. 2007 Apr;29(2):63-70.

PMID:
17484269
35.

Ethnicity and nutrient intake among Arizona WISEWOMAN participants.

Gregory-Mercado KY, Staten LK, Gillespie C, Ranger-Moore J, Thomson CA, Giuliano AR, Will JC, Ford ES, Marshall J.

J Womens Health (Larchmt). 2007 Apr;16(3):379-89.

PMID:
17439383
36.

Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential.

Montironi R, Scarpelli M, Lopez-Beltran A, Mazzucchelli R, Alberts D, Ranger-Moore J, Bartels HG, Hamilton PW, Einspahr J, Bartels PH.

Cell Oncol. 2007;29(1):47-58.

37.
38.

Effects of repeated green tea catechin administration on human cytochrome P450 activity.

Chow HH, Hakim IA, Vining DR, Crowell JA, Cordova CA, Chew WM, Xu MJ, Hsu CH, Ranger-Moore J, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2473-6.

39.

Combination of 4-HPR and oral contraceptive in monkey model of chemoprevention of ovarian cancer.

Brewer M, Ranger-Moore J, Satterfield W, Hao Z, Wang J, Brewer E, Wharton JT, Bast R, Zou C.

Front Biosci. 2007 Jan 1;12:2260-8.

PMID:
17127462
40.

Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progression.

Clouser MC, Harris RB, Roe DJ, Saboda K, Ranger-Moore J, Duckett L, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2292-7.

41.

Carcinogenesis and the hypothesis of phylogenetic reversion.

Bartels PH, Ranger-Moore J, Alberts D, Hess L, Scarpelli M, Montironi R.

Anal Quant Cytol Histol. 2006 Oct;28(5):243-52.

PMID:
17067006
42.

Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses.

Einspahr JG, Xu MJ, Warneke J, Saboda K, Ranger-Moore J, Bozzo P, Duckett L, Goldman R, Lin P, Buckmeier J, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1841-8. Epub 2006 Oct 4.

43.

Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study.

Schneider CK, Melmed RD, Barstow LE, Enriquez FJ, Ranger-Moore J, Ostrem JA.

J Autism Dev Disord. 2006 Nov;36(8):1053-64.

PMID:
16845577
44.

Fruit and vegetable consumption of older Mexican-American women is associated with their acculturation level.

Gregory-Mercado KY, Staten LK, Ranger-Moore J, Thomson CA, Will JC, Ford ES, Guillen J, Larkey LK, Giuliano AR, Marshall J.

Ethn Dis. 2006 Winter;16(1):89-95.

PMID:
16599354
45.

Rate of change in central corneal thickness: a viability indicator for conventional drainage tissues in organ culture.

Wan Z, Brigatti L, Ranger-Moore J, Ethier CR, Stamer WD.

Exp Eye Res. 2006 Jun;82(6):1086-93. Epub 2006 Feb 7.

PMID:
16466713
46.

The evolution of scanning microphotometry: a historical review.

Bartels PH, Descour M, Alberts DS, Ranger-Moore J.

Anal Quant Cytol Histol. 2005 Dec;27(6):323-36.

PMID:
16450789
47.

Karyometry of infiltrating breast lesions.

Frank DH, Davis JR, Ranger-Moore J, Liu Y, Bartels HG, Alberts DS, Bartels PH.

Anal Quant Cytol Histol. 2005 Aug;27(4):195-201.

PMID:
16220830
48.

Poison Control Center--based syndromic surveillance for foodborne illness.

Derby MP, McNally J, Ranger-Moore J, Hulette L, Villar R, Hysong T, MacNeill E, Lebowitz M, Burgess J.

MMWR Suppl. 2005 Aug 26;54:35-40.

PMID:
16177691
49.

Karyometry in rectal mucosa of patients with previous colorectal adenomas.

Ranger-Moore J, Frank D, Lance P, Alberts D, Yozwiak M, Bartels HG, Einspahr J, Bartels PH.

Anal Quant Cytol Histol. 2005 Jun;27(3):134-42.

PMID:
16121634
50.

Karyometry in the early detection and chemoprevention of intraepithelial lesions.

Ranger-Moore J, Alberts DS, Montironi R, Garcia F, Davis J, Frank D, Brewer M, Mariuzzi GM, Bartels HG, Bartels PH.

Eur J Cancer. 2005 Sep;41(13):1875-88.

PMID:
16087328

Supplemental Content

Loading ...
Support Center